Young Joo Lee (Youngjoo Lee)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Cerebrospinal Fluid

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hye Sook Kim, Jong-Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon Kook Lee, Ji-Youn Han
Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. JCO precision oncology 8 (2024)
Hyunsoon Cho, Hoejun Kwon, Se Hyun Kim, Hyung-Min Ahn, Beom K Choi, Geon Kook Lee, Seog-Yun Park, Hyun-Ju Lim, Jung-Ah Hwang, Jiyeon Lim, Ji-Youn Han, Young Joo Lee
Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancer. Cancer (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Su-Hyun Kim, Beung Chul Ahn, Dong-Eun Lee, Ki Hoon Kim, Jae-Won Hyun, Min Jeong Kim, Na Young Park, Ho Jin Kim, Young Joo Lee
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer. International journal of molecular sciences 25 (12) (2024)
Hye Sook Kim, Jong-Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon Kook Lee, Ji-Youn Han
Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. JCO precision oncology 8 (2024)
Sunshin Kim, Young Joo Lee, Bo Ram Song, Hanna Sim, Eun Hye Kang, Mihwa Hwang, Namhee Yu, Sehwa Hong, Charny Park, Beung Chul Ahn, Eun Jin Lim, Kum Hui Hwang, Seog-Yun Park, Jin Ho Choi, Geon Kook Lee, Ji-Youn Han
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers 16 (4) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Hye Sook Kim, Jong-Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon Kook Lee, Ji-Youn Han
Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. JCO precision oncology 8 (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Su-Hyun Kim, Beung Chul Ahn, Dong-Eun Lee, Ki Hoon Kim, Jae-Won Hyun, Min Jeong Kim, Na Young Park, Ho Jin Kim, Young Joo Lee
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer. International journal of molecular sciences 25 (12) (2024)
Su-Hyun Kim, Beung Chul Ahn, Dong-Eun Lee, Ki Hoon Kim, Jae-Won Hyun, Min Jeong Kim, Na Young Park, Ho Jin Kim, Young Joo Lee
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer. International journal of molecular sciences 25 (12) (2024)
Sunshin Kim, Young Joo Lee, Bo Ram Song, Hanna Sim, Eun Hye Kang, Mihwa Hwang, Namhee Yu, Sehwa Hong, Charny Park, Beung Chul Ahn, Eun Jin Lim, Kum Hui Hwang, Seog-Yun Park, Jin Ho Choi, Geon Kook Lee, Ji-Youn Han
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers 16 (4) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Thi-Ngoc Tran, Sanghee Lee, Hak Jin Kim, Young Joo Lee, Thao Minh Tu, Jin-Ho Choi, Jae Won Song, Hyunsoon Cho
Treatment-related cardiovascular events in patients with non-small cell lung cancer: Evidence from real-world data with a competing risks approach. Cancer 130 (8) (2023)
Beung Chul Ahn, Charny Park, Sang-Jin Lee, Sehwa Hong, Ji-Eun Hwang, Kyoungsuk Kwon, Jin Young Kim, Kyung-Hee Kim, Hyae Young Kim, Geon Kook Lee, Young Joo Lee, Ji-Youn Han
Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression. Cancers 15 (18) (2023)
Yu-Ra Choi, Eun Hye Kang, Sunshin Kim, Seog-Yun Park, Ji-Youn Han, Young Joo Lee
Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer. British journal of cancer (2023)
Eun Sang Oh, Sung Ho Moon, Young Joo Lee, Beung Chul Ahn, Jong Yeul Lee, Yang Gun Suh, Joo-Hyun Chung, Moon Soo Kim, Jong Mog Lee, Jin Ho Choi, Tae Hyun Kim
Treatment Outcomes of Proton Beam Therapy for Esophageal Squamous Cell Carcinoma at a Single Institute. Cancers 15 (23) (2023)
Thi-Ngoc Tran, Sanghee Lee, Hak Jin Kim, Young Joo Lee, Thao Minh Tu, Jin-Ho Choi, Jae Won Song, Hyunsoon Cho
Treatment-related cardiovascular events in patients with non-small cell lung cancer: Evidence from real-world data with a competing risks approach. Cancer 130 (8) (2023)
Thi-Ngoc Tran, Sanghee Lee, Hak Jin Kim, Young Joo Lee, Thao Minh Tu, Jin-Ho Choi, Jae Won Song, Hyunsoon Cho
Treatment-related cardiovascular events in patients with non-small cell lung cancer: Evidence from real-world data with a competing risks approach. Cancer (2023)
Young Joo Lee, Hye Ryun Kim, Min Hee Hong, Ki Hyeong Lee, Keon Uk Park, Geon Kook Lee, Hyae Young Kim, Soo-Hyun Lee, Kun Young Lim, Sung Jin Yoon, Byoung Chul Cho, Ji-Youn Han
A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation. Cancer (2022)
Jin Ho Choi, Jong Mog Lee, Moon Soo Kim, Young Joo Lee, Yang Gun Suh, Sung Uk Lee, Doo Yeul Lee, Eun Sang Oh, Tae Hyun Kim, Sung Ho Moon
A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute. Cancers 14 (8) (2022)
Yu-Ra Choi, Youngnam Cho, Seog-Yun Park, Sunshin Kim, Myungsun Shin, Yongdoo Choi, Dong Hoon Shin, Ji-Youn Han, Young Joo Lee
Early On-Treatment Prediction of the Mechanisms of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors. Cancers 14 (6) (2022)
Wonyoung Choi, Hyun-Ju Lim, Seog-Yun Park, Ji-Youn Han, Heung Tae Kim, Jin Soo Lee, Young Joo Lee
Ceritinib-Induced Organizing Pneumonia in Lung Cancer: A Retrospective Analysis. Targeted oncology 15 (4) (2021)
Young Joo Lee, Youngnam Cho, Eun Young Park, Seong-Yun Park, Kum Hui Hwang, Ji-Youn Han
One-Step Polymerase Chain Reaction-Free Nanowire-Based Plasma Cell-Free DNA Assay to Detect EML4-ALK Fusion and to Monitor Resistance in Lung Cancer. The oncologist 26 (10) (2021)
Hongsik Kim, Dong-Wan Kim, Miso Kim, Young Joo Lee, Hee Kyung Ahn, Jang Ho Cho, Il Hwan Kim, Yun-Gyoo Lee, Seong-Hoon Shin, Song Ee Park, Jiyoon Jung, Eun Joo Kang, Myung-Ju Ahn
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11). Cancer (2021)
Wonyoung Choi, Youngnam Cho, Seog-Yun Park, Kum Hui Hwang, Ji-Youn Han, Young Joo Lee
A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis. Journal of cancer research and clinical oncology 147 (1) (2020)